Molina Healthcare (NYSE:MOH – Get Free Report) is anticipated to issue its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.43 per share and revenue of $10.9046 billion for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 6, 2026 at 8:00 AM ET.
Molina Healthcare Stock Up 1.5%
MOH stock opened at $186.93 on Thursday. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. The firm has a 50-day moving average of $169.23 and a two-hundred day moving average of $172.09. Molina Healthcare has a 12 month low of $133.40 and a 12 month high of $359.97. The company has a market cap of $10.13 billion, a price-to-earnings ratio of 11.57 and a beta of 0.49.
Analysts Set New Price Targets
MOH has been the topic of a number of research analyst reports. Barclays lifted their target price on Molina Healthcare from $144.00 to $164.00 and gave the company an “underweight” rating in a research report on Monday, January 5th. Truist Financial set a $175.00 price objective on shares of Molina Healthcare in a report on Friday, October 24th. Wells Fargo & Company upped their target price on shares of Molina Healthcare from $165.00 to $208.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Cantor Fitzgerald dropped their price target on shares of Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating for the company in a research report on Friday, October 24th. Finally, Mizuho set a $220.00 price target on shares of Molina Healthcare in a research note on Friday, January 9th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $193.47.
Insiders Place Their Bets
In other Molina Healthcare news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the sale, the director directly owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.26% of the stock is currently owned by company insiders.
Institutional Trading of Molina Healthcare
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC raised its position in shares of Molina Healthcare by 165.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,935 shares of the company’s stock worth $576,000 after buying an additional 1,207 shares during the period. Scientech Research LLC grew its position in Molina Healthcare by 101.3% during the third quarter. Scientech Research LLC now owns 1,987 shares of the company’s stock valued at $380,000 after acquiring an additional 1,000 shares during the period. Lighthouse Investment Partners LLC acquired a new stake in Molina Healthcare during the third quarter worth about $377,000. Banco Bilbao Vizcaya Argentaria S.A. raised its holdings in shares of Molina Healthcare by 44.2% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 1,462 shares of the company’s stock worth $280,000 after purchasing an additional 448 shares during the period. Finally, Brooklyn Investment Group lifted its stake in shares of Molina Healthcare by 222.3% in the 3rd quarter. Brooklyn Investment Group now owns 2,008 shares of the company’s stock valued at $384,000 after purchasing an additional 1,385 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Further Reading
- Five stocks we like better than Molina Healthcare
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
